Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Non-cash Items (2018 - 2025)

InspireMD posted quarterly Non-cash Items of $1.6 million for Q4 2025, up 150.09% year-on-year from $644882.0 in Q4 2024, and up 150.09% on a QoQ basis from $644882.0 in Q4 2024.

InspireMD (NSPR) has 8 years of Non-cash Items data on file, last reported at $1.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items rose 150.09% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (up 150.09% YoY), and the FY2025 full-year result was $1.6 million, up 150.09% from the prior year.
  • Non-cash Items for Q4 2025 stood at $1.6 million, up from $644882.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $123.1 million in Q4 2022 and bottomed at $28360.0 in Q4 2021.
  • The 5-year median for Non-cash Items is $644882.0 (2024), against an average of $25.1 million.
  • The widest annual swing landed in 2022, when Non-cash Items jumped 434014.95%; it then sank 99.82% in 2023.
  • A 5-year view of Non-cash Items shows it stood at $28360.0 in 2021, then surged by 434014.95% to $123.1 million in 2022, then tumbled by 99.82% to $215709.0 in 2023, then jumped by 198.96% to $644882.0 in 2024, then soared by 150.09% to $1.6 million in 2025.
  • The last three Non-cash Items figures came in at $1.6 million (Q4 2025), $644882.0 (Q4 2024), and $215709.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 InspireMD 64.01 Mn 9.80 Mn 1.18 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.61 Mn
Dec 31, 2025 1.61 Mn
Dec 31, 2024 644,882.00
Dec 31, 2024 644,882.00
Dec 31, 2023 215,709.00
Dec 31, 2023 215,709.00
Dec 31, 2022 123.12 Mn
Dec 31, 2022 123.12 Mn
Dec 31, 2021 28,360.00
Dec 31, 2021 28,360.00
Dec 31, 2020 15.00
Dec 31, 2020 15.00
Dec 31, 2019 160.00
Dec 31, 2019 160.00
Dec 31, 2018 139.00
Dec 31, 2018 139.00